{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:04:26Z","timestamp":1788721466771,"version":"build-2803163510"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Colorectal cancer is a sporadic, hereditary, or familial based disease in its origin, caused due to diverse set of mutations in large intestinal epithelial cells. Colorectal cancer (CRC) is a common and deadly disease that accounts for the 4<jats:sup>th<\/jats:sup> worldwide highly variable malignancy. For the early detection of CRC, the most common predictive biomarker found endogenously are KRAS and ctDNA\/cfDNA along with <jats:italic>SEPT9<\/jats:italic> methylated DNA. Early detection and screening for CRC are necessary and multiple methods can be employed to screen and perform early diagnosis of CRC. Colonoscopy, an invasive method is most prevalent for diagnosing CRC or confirming the positive result as compared to other screening methods whereas several non-invasive techniques such as molecular analysis of breath, urine, blood, and stool can also be performed for early detection. Interestingly, widely used medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation have reported chemopreventive impact on gastrointestinal malignancies, especially CRC in several epidemiological and preclinical types of research. NSAID acts by inhibiting two cyclooxygenase enzymes, thereby preventing the synthesis of prostaglandins (PGs) and causing NSAID-induced apoptosis and growth inhibition in CRC cells. This review paper majorly focuses on the diversity of natural and synthetic biomarkers and various techniques for the early detection of CRC. An approach toward current advancement in CRC detection techniques and the role of NSAIDs in CRC chemoprevention has been explored systematically. Several prominent governing mechanisms of the anti-cancer effects of NSAIDs and their synergistic effect with statins for an effective chemopreventive measure have also been discussed in this review paper.<\/jats:p>","DOI":"10.3389\/fmed.2023.1130710","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T05:57:40Z","timestamp":1678082260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Gowhar","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihad Ashraf","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena","family":"Elsori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andleeb","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Tanzeelah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Maryam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaan","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Salik","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaad Ma","family":"Babker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azhar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/FGSTR.2022.1021050","article-title":"Modulation of tumor environment in colorectal cancer \u2013 could gut microbiota be a key player?","volume":"1","author":"Duarte Mendes","year":"2022","journal-title":"Frontiers in Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/cancers15030688","article-title":"Autoimmune and metabolic diseases and the risk of early-onset colorectal cancer, a Nationwide nested case\u2013control study","volume":"15","author":"Lundqvist","year":"2023","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-540-85516-3_1047\/COVER","article-title":"Cancer colon","author":"Knowlton","year":"2013","journal-title":"Encyclo Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00439-019-02030-8","article-title":"Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer","volume":"138","author":"Bien","year":"2019","journal-title":"Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/DCR.0000000000001305","article-title":"Randomized clinical trial: a normocaloric low-fiber diet the day before colonoscopy is the most effective approach to bowel preparation in colorectal cancer screening colonoscopy","volume":"62","author":"Alvarez-Gonzalez","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9.23.1","DOI":"10.1002\/cpph.19","article-title":"Biomarkers\u2014A General Review","volume":"76","author":"Aronson","year":"2017","journal-title":"Curr Protoc Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/CANCERS12082160","article-title":"The pathologic and molecular landscape of esophageal squamous cell carcinogenesis","volume":"12","author":"Businello","year":"2020","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.3390\/ijms21155311","article-title":"Biomarkers in colorectal cancer: current research and future prospects","volume":"21","author":"Ogunwobi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41575-022-00612-y","article-title":"Current and future colorectal cancer screening strategies","volume":"19","author":"Shaukat","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/diagnostics11030543","article-title":"The entire intestinal tract surveillance using capsule endoscopy after immune checkpoint inhibitor administration: a prospective observational study","volume":"11","author":"Shimozaki","year":"2021","journal-title":"Diagnostics"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mcna.2018.08.010","article-title":"Colorectal cancer screening: is colonoscopy the best option?","volume":"103","author":"Liang","year":"2019","journal-title":"Med Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12029-016-9810-z","article-title":"Stool investigations for colorectal cancer screening: from occult blood test to DNA analysis","volume":"47","author":"Iannone","year":"2016","journal-title":"J Gastrointest Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e2122328","DOI":"10.1001\/jamanetworkopen.2021.22328","article-title":"Rising use of multitarget stool DNA testing for colorectal cancer","volume":"4","author":"Hoffman","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e34589","DOI":"10.2196\/34589","article-title":"Colorectal cancer incidence, inequalities, and prevention priorities in urban Texas: surveillance study with the \u201csurveil\u201d software package","volume":"8","author":"Donegan","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jtho.2018.11.023","article-title":"Biomarkers in lung cancer screening: achievements, promises, and challenges","volume":"14","author":"Seijo","year":"2019","journal-title":"J Thorac Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12859-021-04411-1\/TABLES\/2","article-title":"Bioinformatics screening of biomarkers related to liver cancer","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Bioinform"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3748\/WJG.V24.I26.2818","article-title":"Biomarkers of gastric cancer: current topics and future perspective","volume":"24","author":"Matsuoka","year":"2018","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3748\/wjg.v22.i5.1745","article-title":"Colorectal cancer tumour markers and biomarkers: recent therapeutic advances","volume":"22","author":"Lech","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.21037\/gs-20-544","article-title":"Role of biomarkers for early detection of ovarian cancer recurrence","volume":"9","author":"Giampaolino","year":"2020","journal-title":"Gland Surg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/PGPM.S136026","article-title":"Emerging biomarkers in the diagnosis of prostate cancer","volume":"11","author":"Filella","year":"2018","journal-title":"Pharmgenomics Pers Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","article-title":"Triple-negative breast cancer: promising prognostic biomarkers currently in development","volume":"21","author":"Sukumar","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jop.12171","article-title":"Molecular and cellular cues of diet-associated oral carcinogenesis--with an emphasis on areca-nut-induced oral cancer development","volume":"44","author":"Li","year":"2015","journal-title":"J Oral Pathol Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e037945","DOI":"10.1136\/bmjopen-2020-037945","article-title":"The association between cigarette smoking, cancer screening, and cancer stage: a prospective study of the women\u2019s health initiative observational cohort","volume":"10","author":"Eng","year":"2020","journal-title":"BMJ Open"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"djx030","DOI":"10.1093\/JNCI\/DJX030","article-title":"Annual report to the nation on the status of cancer, 1975-2014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/cncr.31551","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics","volume":"124","author":"Cronin","year":"2018","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s13193-017-0711-9","article-title":"Current status and future directions in colorectal cancer","volume":"9","author":"Meyer","year":"2018","journal-title":"Indian J Surg Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.14309\/ajg.0000000000000803","article-title":"Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis","volume":"115","author":"Botteri","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10552-014-0513-0","article-title":"Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum","volume":"26","author":"Figueiredo","year":"2015","journal-title":"Cancer Causes Control"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/cclm-2019-0038","article-title":"Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review","volume":"58","author":"Olsen","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/JAMA.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/JAMA.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5539\/GJHS.V8N6P256","article-title":"Determination of effective factors on survival of GI cancers: results of five years follow up in Iranian population","volume":"8","author":"Zargar","year":"2016","journal-title":"Global J Health Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1200\/JCO.2015.63.9674","article-title":"Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology provisional clinical opinion update 2015","volume":"34","author":"Allegra","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/bjc.2016.303","article-title":"Renewed interest in the progesterone receptor in breast cancer","volume":"115","author":"Lim","year":"2016","journal-title":"Br J Cancer"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1245\/s10434-016-5717-y","article-title":"Use of tumor markers in gastrointestinal cancers: surgeon perceptions and cost-benefit trade-off analysis","volume":"24","author":"Acharya","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"103224","DOI":"10.1016\/j.critrevonc.2021.103224","article-title":"Serum tumour markers in germ cell tumours: from diagnosis to cure","volume":"159","author":"Pedrazzoli","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jons.2017.01.001","article-title":"Tumor markers of breast cancer: new prospectives","volume":"3","author":"Kabel","year":"2017","journal-title":"J Oncol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41568-021-00389-3","article-title":"Synthetic biomarkers: a twenty-first century path to early cancer detection","volume":"21","author":"Kwong","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1021\/acssensors.9b02194","article-title":"Tumor-penetrating hierarchically structured Nanomarker for imaging-guided urinary monitoring of cancer","volume":"5","author":"Zhang","year":"2020","journal-title":"ACS Sens"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5527\/wjn.v4.i1.57","article-title":"Biomarkers in chronic kidney disease, from kidney function to kidney damage","volume":"4","author":"Lopez-Giacoman","year":"2015","journal-title":"World J Nephrol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.hpb.2020.06.006","article-title":"Identification of liver lesions using fluorescence imaging: comparison of methods for administering indocyanine green","volume":"23","author":"Kobayashi","year":"2021","journal-title":"HPB"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.7314\/APJCP.2015.16.17.7967","article-title":"Dietary practices, addictive behavior and bowel habits and risk of early onset colorectal cancer: a case control study","volume":"16","author":"Khan","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.20517\/evcna.2022.20","article-title":"Cell-free DNA as a biomarker in cancer","volume":"3","author":"Eibl","year":"2022","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3892\/ol.2016.5027","article-title":"Mechanism analysis of colorectal cancer according to the microRNA expression profile","volume":"12","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/BS.ACC.2015.07.004","article-title":"SEPT9: a specific circulating biomarker for colorectal cancer","volume":"72","author":"Song","year":"2015","journal-title":"Adv Clin Chem"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/1055-9965.EPI-16-0006","article-title":"Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer","volume":"25","author":"Dong","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3892\/ol.2016.5109","article-title":"Methylation of promoter region of CDX2 gene in colorectal cancer","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol Lett"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/0284186X.2019.1691258","article-title":"Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study","volume":"59","author":"Mezheyeuski","year":"2020","journal-title":"Acta Oncol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.3748\/wjg.v23.i28.5086","article-title":"Colorectal cancer screening: An updated review of the available options","volume":"23","author":"Issa","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e004336","DOI":"10.1136\/jitc-2021-004336","article-title":"Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186","volume":"10","author":"Dettling","year":"2022","journal-title":"J Immunother Cancer"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10120-020-01064-6","article-title":"A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis","volume":"23","author":"Lopes","year":"2020","journal-title":"Gastric Cancer"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"77683","DOI":"10.18632\/oncotarget.12760","article-title":"Integrin \u03b12\u03b21 inhibits MST1 kinase phosphorylation and activates yes-associated protein oncogenic signaling in hepatocellular carcinoma","volume":"7","author":"Wong","year":"2016","journal-title":"Oncotarget"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000438614","article-title":"Telomere length as a prognostic factor for overall survival in colorectal cancer patients","volume":"38","author":"Jia","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/joim.13171","article-title":"Aspects of colorectal cancer screening, methods, age and gender","volume":"289","author":"Hultcrantz","year":"2021","journal-title":"J Intern Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature04659","article-title":"A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth","volume":"441","author":"Kim","year":"2006","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.7150\/ijms.44439","article-title":"The role of Cyclooxygenase-2 in colorectal cancer","volume":"2020","author":"Sheng","year":"2020","journal-title":"Int J Med Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4149\/neo_2019_190531N475","article-title":"KRT15 overexpression predicts poor prognosis in colorectal cancer","volume":"67","author":"Rao","year":"2020","journal-title":"Neoplasma"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmed.2015.00011","article-title":"Molecular and pathogenetic aspects of tumor budding in colorectal cancer","volume":"2","author":"Dawson","year":"2015","journal-title":"Front Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.2147\/CMAR.S178567","article-title":"Celecoxib in breast cancer prevention and therapy","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.3748\/wjg.v20.i22.6786","article-title":"Colorectal cancer: from prevention to personalized medicine","volume":"20","author":"Binefa","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12876-022-02264-3\/TABLES\/5","article-title":"A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA","volume":"22","author":"Ma","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","article-title":"Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer","volume":"15","author":"Oh","year":"2013","journal-title":"J Mol Diagn"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/cncr.28227","article-title":"Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah","volume":"120","author":"Tuohy","year":"2014","journal-title":"Cancer"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2176056","DOI":"10.1155\/2018\/2176056","article-title":"Treatment of elderly patients with colorectal cancer","volume":"2018","author":"Itatani","year":"2018","journal-title":"Biomed Res Int"},{"key":"ref67","first-page":"2114","article-title":"Association of physician adenoma detection rates with postcolonoscopy colorectal cancer","volume-title":"Jama","author":"Schottinger, JE, Jensen, CD, Ghai, NR, Chubak J, Lee, JK, Kamineni, A","year":"2022"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1056\/NEJMoa1309086","article-title":"Adenoma detection rate and risk of colorectal cancer and death","volume":"370","author":"Corley","year":"2014","journal-title":"N Engl J Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa0907667","article-title":"Quality indicators for colonoscopy and the risk of interval cancer","volume":"362","author":"Kaminski","year":"2010","journal-title":"N Engl J Med"},{"key":"ref70","first-page":"575","article-title":"A highly predictive model for diagnosis of colorectal neoplasms using plasma microRNA: improving specificity and sensitivity","volume-title":"Annals of Surgery","year":"2016"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hoc.2022.02.001","article-title":"Screening for colorectal cancer","volume":"36","author":"Gupta","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N Engl J Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminoncol.2004.09.031","article-title":"Screening for colorectal cancer - now and the near future","volume":"32","author":"Bromer","year":"2005","journal-title":"Semin Oncol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/14737140.2017.1392243","article-title":"Screening of colorectal cancer: present and future","volume":"17","author":"Maida","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1055\/a-1185-3109","article-title":"Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2020","volume":"52","author":"Hassan","year":"2020","journal-title":"Endoscopy"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/ijms23020852","article-title":"Novel diagnostic biomarkers in colorectal cancer","volume":"23","author":"Zygulska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/JAMA.2021.4417","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force","volume":"325","author":"Lin","year":"2021","journal-title":"JAMA"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4251\/wjgo.v10.i1.15","article-title":"Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection","volume":"10","author":"Wang","year":"2018","journal-title":"World J Gastrointest Oncol"},{"key":"ref79","unstructured":"2013"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03321-8","article-title":"The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/cancers13092025","article-title":"A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis","volume":"13","author":"Sawicki","year":"2021","journal-title":"Cancers"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/00325481.2016.1135035","article-title":"A novel multitarget stool DNA test for colorectal cancer screening","volume":"128","author":"Malik","year":"2016","journal-title":"Postgrad Med"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/cancers14030817","article-title":"Use of omics technologies for the detection of colorectal cancer biomarkers","volume":"14","author":"Alorda-Clara","year":"2022","journal-title":"Cancers"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/JAMA.2015.9936","article-title":"Nonsteroidal anti-inflammatory drugs","volume":"314","author":"Jin","year":"2015","journal-title":"JAMA"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.prostaglandins.2015.06.001","article-title":"NSAIDS and gastrointestinal cancer","volume":"120","author":"Piazuelo","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nefroe.2016.01.001","article-title":"Drug-related acute renal failure in hospitalised patients","volume":"35","author":"Iavecchia","year":"2015","journal-title":"Nefrolog\u00eda"},{"key":"ref88","first-page":"1095","article-title":"The role of cyclooxygenase-2 in colorectal cancer","volume-title":"Int.l J. Med. Sci.","year":"2020"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J Lipid Res"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"e045961","DOI":"10.1136\/bmjopen-2020-045961","article-title":"Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies","volume":"11","author":"B\u00e4umler","year":"2021","journal-title":"BMJ Open"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"684162","DOI":"10.3389\/fphar.2021.684162","article-title":"Pharmacogenomics of NSAID-induced upper gastrointestinal toxicity","volume":"12","author":"McEvoy","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/carcin\/bgv147","article-title":"Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China","volume":"36","author":"Zhang","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/ijms23031432","article-title":"NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase","volume":"23","author":"Kolawole","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/ije\/dym193","article-title":"Colorectal cancer risk, chronic illnesses, operations and medications: case\u2013control results from the Melbourne colorectal cancer study","volume":"36","author":"Kune","year":"2007","journal-title":"Int J Epidemiol"},{"key":"ref96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjorl.2022.12.004","article-title":"Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study","volume-title":"Brazilian J Otorhinolaryngol","author":"Ohara","year":"2022"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2019.12.027","article-title":"Proprotein convertases: key players in inflammation-related malignancies and metastasis","volume":"473","author":"Siegfried","year":"2020","journal-title":"Cancer Lett"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"e1039764","DOI":"10.1080\/2162402X.2015.1039764","article-title":"Restoring inflammatory balance as a potential preventive strategy for inflammation induced cancer","volume":"4","author":"Hefetz-Sela","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21239018","article-title":"Mechanisms of colorectal cancer prevention by aspirin-a literature review and perspective on the role of COX-dependent and -independent pathways","volume":"21","author":"Sankaranarayanan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biomedicines5030043","article-title":"Aspirin prevention of colorectal cancer: focus on NF-\u03baB Signalling and the nucleolus","volume":"5","author":"Chen","year":"2017","journal-title":"Biomedicine"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12935-015-0260-7\/TABLES\/1","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"2048731","DOI":"10.1155\/2016\/2048731","article-title":"Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy","volume":"2016","author":"Pang","year":"2016","journal-title":"Stem Cells Int"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ph11040101","article-title":"Cyclooxygenase-1 (COX-1) and COX-1 inhibitors in cancer: a review of oncology and medicinal chemistry literature","volume":"11","author":"Pannunzio","year":"2018","journal-title":"Pharmaceuticals"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"106506","DOI":"10.1016\/j.phrs.2022.106506","article-title":"The specific deletion of cyclooxygenase-1 in megakaryocytes\/platelets reduces intestinal polyposis in ApcMin\/+ mice","volume":"185","author":"Bruno","year":"2022","journal-title":"Pharmacol Res"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1021\/acs.chemrev.0c00215","article-title":"Structural and chemical biology of the interaction of cyclooxygenase with substrates and non-steroidal anti-inflammatory drugs","volume":"120","author":"Rouzer","year":"2020","journal-title":"Chem Rev"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/cancers13040594","article-title":"Non-steroidal anti-inflammatory drugs in colorectal cancer chemoprevention","volume":"13","author":"Maniewska","year":"2021","journal-title":"Cancer"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1093\/hmg\/ddab208","article-title":"From APC to the genetics of hereditary and familial colon cancer syndromes","volume":"30","author":"Olkinuora","year":"2021","journal-title":"Hum Mol Genet"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1016\/j.febslet.2005.06.049","article-title":"Diclofenac attenuates Wnt\/\u03b2-catenin signaling in colon cancer cells by activation of NF-\u03baB","volume":"579","author":"Cho","year":"2005","journal-title":"FEBS Lett"},{"key":"ref109","unstructured":"2002"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41416-022-01882-8","article-title":"Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies","volume":"127","author":"Zaman","year":"2022","journal-title":"Br J Cancer"},{"key":"ref111","first-page":"105","article-title":"Epidemiology of colorectal cancer","volume":"7","author":"Marley","year":"2016","journal-title":"Int J Mol Epidemiol Genet"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/ajg.2017.212","article-title":"Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management","volume":"112","author":"Kanth","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/15384047.2015.1071741","article-title":"Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas","volume":"21","author":"Santoro","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/cells10061487","article-title":"The role of prostaglandins in different types of cancer","volume":"10","author":"Jara-Guti\u00e9rrez","year":"2021","journal-title":"Cells"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.7314\/APJCP.2015.16.4.1553","article-title":"Cyclooxygenase-2 expression in invasive breast carcinomas of no special type and correlation with pathological profiles suggest a role in tumorigenesis rather than cancer progression","volume":"16","author":"Misron","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: importance of dose\u2013response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J Intern Med"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S41021-016-0033-0\/TABLES\/2","article-title":"Effects of NSAIDs on the risk factors of colorectal cancer: a mini review","volume":"38","author":"Hamoya","year":"2016","journal-title":"Genes Environ"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0959-8049(99)00333-0","article-title":"The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action","volume":"36","author":"Smith","year":"2000","journal-title":"Eur J Cancer"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e0245581","DOI":"10.1371\/journal.pone.0245581","article-title":"Prognostic significance of BIRC7\/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin","volume":"16","author":"Faruk","year":"2021","journal-title":"PLoS One"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bbrc.2015.07.004","article-title":"Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-\u03baB activation mediated by IL-4\/miR-324-5p\/CUEDC2 axis","volume":"464","author":"Song","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1038\/onc.2011.655","article-title":"Sulindac inhibits tumor cell invasion by suppressing NF-\u03baB-mediated transcription of microRNAs","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1038\/sj.onc.1210891","article-title":"The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-\u03baB","volume":"27","author":"Loveridge","year":"2008","journal-title":"Oncogene"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0092-8674(00)00122-7","article-title":"Linking colorectal cancer to Wnt signaling","volume":"103","author":"Bienz","year":"2000","journal-title":"Cells"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.drudis.2020.06.008","article-title":"PDE5 and PDE10 inhibition activates cGMP\/PKG signaling to block Wnt\/\u03b2-catenin transcription, cancer cell growth, and tumor immunity","volume":"25","author":"Piazza","year":"2020","journal-title":"Drug Discov Today"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"G59","DOI":"10.1152\/ajpgi.00101.2014","article-title":"Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention","volume":"309","author":"Fajardo","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS12123701","article-title":"Inflammation is a mediating factor in the association between lifestyle and fatigue in colorectal cancer patients","volume":"12","author":"Wesselink","year":"2020","journal-title":"Cancers"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/FPHAR.2019.00152\/BIBTEX","article-title":"Curcumin nanoformulations for colorectal cancer: a review","volume":"10","author":"Wong","year":"2019","journal-title":"Front Pharmacol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1158\/1940-6207.CAPR-11-0129","article-title":"Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system","volume":"4","author":"Chaudhary","year":"2011","journal-title":"Cancer Prev Res"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3390\/IJMS19082332","article-title":"Clinically relevant anti-inflammatory agents for chemoprevention of colorectal cancer: new perspectives","volume":"19","author":"Mohammed","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40495-015-0042-x","article-title":"NSAIDs and colorectal cancer control: promise and challenges","volume":"1","author":"Tsioulias","year":"2015","journal-title":"Curr Pharmacol Rep"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","article-title":"3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the risk of cancer: a nested case-control study","volume":"160","author":"Blais","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2036.2005.02335.x","article-title":"Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer","volume":"21","author":"Jalving","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1158\/0008-5472.CAN-05-4428","article-title":"Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats","volume":"66","author":"Reddy","year":"2006","journal-title":"Cancer Res"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jbior.2014.10.003","article-title":"Lipid rafts as major platforms for signaling regulation in cancer","volume":"57","author":"Mollinedo","year":"2015","journal-title":"Adv Biol Regul"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1172\/JCI200519935","article-title":"Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts","volume":"115","author":"Zhuang","year":"2005","journal-title":"J Clin Invest"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrc725","article-title":"RHO-GTPases and cancer","volume":"2","author":"Sahai","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"e0192790","DOI":"10.1371\/journal.pone.0192790","article-title":"MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB","volume":"13","author":"Niu","year":"2018","journal-title":"PLoS One"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/15384047.2022.2104561","article-title":"Colorectal cancer chemoprevention: is aspirin still in the game?","volume":"23","author":"Grancher","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1136\/gutjnl-2013-305827","article-title":"The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial","volume":"63","author":"Ishikawa","year":"2014","journal-title":"Gut"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"Gurpinar","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10689-020-00189-y","article-title":"Chemoprevention in familial adenomatous polyposis: past, present and future","volume":"20","author":"Kemp Bohan","year":"2021","journal-title":"Familial Cancer"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/bjc.2011.289","article-title":"Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?","volume":"105","author":"Langley","year":"2011","journal-title":"Br J Cancer"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cells"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"djw152","DOI":"10.1093\/JNCI\/DJW152","article-title":"Selenium supplementation for prevention of colorectal adenomas and risk of associated type 2 diabetes","volume":"108","author":"Thompson","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/cas.14149","article-title":"Chemoprevention of colorectal cancer: past, present, and future","volume":"110","author":"Umezawa","year":"2019","journal-title":"Cancer Sci"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","article-title":"A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas","volume":"131","author":"Baron","year":"2006","journal-title":"Gastroenterology"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"e021869","DOI":"10.1136\/bmjopen-2018-021869","article-title":"Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden","volume":"8","author":"Brusselaers","year":"2018","journal-title":"BMJ Open"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/M16-0461","article-title":"Management of Gout: a systematic review in support of an American College of Physicians Clinical Practice Guideline","volume":"166","author":"Shekelle","year":"2017","journal-title":"Ann Intern Med"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"e114633","DOI":"10.1371\/journal.pone.0114633","article-title":"Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study","volume":"9","author":"Shebl","year":"2014","journal-title":"PLoS One"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-981-15-2933-7_5","article-title":"Pharmacology of analgesics","author":"Shimoji","year":"2021","journal-title":"Chronic Pain Management in General and Hospital Practice"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4082\/kjfm.21.0103","article-title":"Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates","volume":"43","author":"Itani","year":"2022","journal-title":"Korean J Fam Med"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"djv170","DOI":"10.1093\/jnci\/djv170","article-title":"Aspirin, ibuprofen, and the risk of colorectal cancer in lynch syndrome","volume":"107","author":"Ouakrim","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/TA.0000000000000755","article-title":"Nonopioid management of acute pain associated with trauma: focus on pharmacologic options","volume":"79","author":"Oyler","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/BIOMEDICINES8100414","article-title":"Genetic alterations of metastatic colorectal cancer","volume":"8","author":"Testa","year":"2020","journal-title":"Biomedicine"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"814","DOI":"10.7326\/M15-2117","article-title":"Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the U.S. preventive services task force","volume":"164","author":"Chubak","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3322\/caac.21448","article-title":"Recent progress in lynch syndrome and other familial colorectal cancer syndromes","volume":"68","author":"Boland","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: the promise of precision chemoprevention","volume":"16","author":"Drew","year":"2016","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1130710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T05:57:51Z","timestamp":1678082271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1130710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":164,"alternative-id":["10.3389\/fmed.2023.1130710"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1130710","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"article-number":"1130710"}}